We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

126 hedge funds and large institutions have $127M invested in SANGAMO THERAPEUTICS INC in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

203% more call options, than puts

Call options by funds: $3.12M | Put options by funds: $1.03M

58.69% more ownership

Funds ownership: 0% → 58.69% (+59%)

25% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 32

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

2% more funds holding

Funds holding: 124 → 126 (+2)

36% less capital invested

Capital invested by funds: $196M → $127M (-$69.7M)

Holders
126
Holders Change
+2
Holders Change %
+1.61%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
40
Reduced
32
Closed
18
Calls
$3.12M
Puts
$1.03M
Net Calls
+$2.09M
Net Calls Change
-$1.79M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$3.05M
2
NC
Nexthera Capital
New York
+$1.83M
3
OM
Opaleye Management
Massachusetts
+$1.46M
4
BFA
BlackRock Fund Advisors
California
+$1.27M
5
WA
Wasatch Advisors
Utah
+$1,000K

Top Sellers

Rank Fund Capital Flow
1
VOYA Investment Management
VOYA Investment Management
Georgia
-$4.82M
2
NI
Numeric Investors
Massachusetts
-$4.64M
3
State Street
State Street
Massachusetts
-$4.52M
4
RCM
RA Capital Management
Massachusetts
-$4.16M
5
CAM
Cormorant Asset Management
Massachusetts
-$2.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
FMT
101
First Mercantile Trust
Tennessee
$21K -$2.31K -633 -9%
LTFS
102
Ladenburg Thalmann Financial Services
Florida
$21K +$8.38K +2,300 +51%
DADC
103
D.A. Davidson & Co
Montana
$17K +$1.49K +409 +8%
BlackRock
104
BlackRock
New York
$16K -$2.81K -773 -13%
BCMIO
105
Beacon Capital Management Inc (Ohio)
Ohio
$15K – – –
Canada Life
106
Canada Life
Manitoba, Canada
$15K – – –
US Bancorp
107
US Bancorp
Minnesota
$15K – – –
VCM
108
Vigilant Capital Management
Maine
$15K – – –
MAM
109
Meeder Asset Management
Ohio
$13K +$15.3K +4,204 New
SPIA
110
Steward Partners Investment Advisory
New York
$13K +$16.2K +4,438 New
NCM
111
Nelson Capital Management
California
$10K – – –
CG
112
Cutler Group
California
$7K -$14.2K -3,900 -61%
Zurich Cantonal Bank
113
Zurich Cantonal Bank
Switzerland
$7K – – –
BWP
114
Baldwin Wealth Partners
Massachusetts
$5K – – –
JP Morgan Chase
115
JP Morgan Chase
New York
$4K +$4.81K +1,320 New
SIM
116
Sonora Investment Management
Arizona
$3.96K – – –
BNP Paribas Financial Markets
117
BNP Paribas Financial Markets
France
$3.7K -$13K -3,578 -75%
AF
118
Allworth Financial
California
$3K – – –
BKA
119
Brick & Kyle Associates
Pennsylvania
$3K – – –
MFS
120
MSI Financial Services
Massachusetts
$2K – – –
Bank of Montreal
121
Bank of Montreal
Ontario, Canada
$1K – – –
Fifth Third Bancorp
122
Fifth Third Bancorp
Ohio
$1K – – –
PA
123
Perceptive Advisors
New York
$1K – – –
TFA
124
Transamerica Financial Advisors
Florida
$1K +$426 +117 New
NI
125
Numeric Investors
Massachusetts
– -$4.64M -1,003,313 Closed
2 3 4
5
6

SGMO Hedge Fund Activity: Q4 2016 in Review

126 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2016, worth a combined $127M — down 36% from $196M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SGMO positions and 18 closed out — a net gain of 4 holders — while 40 added to existing stakes and 32 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $3.05M. The largest seller was VOYA Investment Management, cutting an estimated $4.82M.

  • 126 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2016, up from 124 in Q3 2016.
  • Funds reported $127M of SANGAMO THERAPEUTICS INC stock for Q4 2016, down 36% quarter-over-quarter.
  • 22 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2016 and 18 closed out, a net change of +4 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q4 2016 was Deerfield Management, an estimated $3.05M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q4 2016 was VOYA Investment Management, an estimated $4.82M sold.

Based on aggregated 13F filings for Q4 2016.